The MHC class I ligand-generating system: Roles of immunoproteasomes and the interferon-γ-inducible proteasome activator PA28

Immunological Reviews

Volumn 163, Issue , 1998, Pages 161-176

  Tanaka, Keiji ^a,c   Kasahara, Masanori ^b,c,d  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^d GRADUATE UNIVERSITY FOR ADVANCED STUDIES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; LIGAND; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; PROTEASOME;

ANTIGENICITY; ENZYME STRUCTURE; ENZYME SUBUNIT; EUKARYOTE; IMMUNOMODULATION; MAJOR HISTOCOMPATIBILITY COMPLEX; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW;

AMINO ACID SEQUENCE; ANIMALS; ANTIGEN PRESENTATION; CHROMOSOME MAPPING; CYSTEINE ENDOPEPTIDASES; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; INTERFERON TYPE II; LIGANDS; MOLECULAR SEQUENCE DATA; MULTIENZYME COMPLEXES; MUSCLE PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; PROTEIN CONFORMATION; PROTEINS; UBIQUITINS;

EID: 0031819536     PISSN: 01052896     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-065X.1998.tb01195.x     Document Type: Review

References (127)

1. Germain RN, Margulies DH. The biochemistry and cell biology of antigen processing and presentation. Annu Rev Immunol 1993;11:403-450.
2. Heemels M-T, Ploegh H. Generation, translocation, and presentation of MHC class I-restricted peptides. Annu Rev Biochem 1995;64:463-491.
3. Monaco JJ, Nandi D. The genetics of proteasomes and antigen processing. Annu Rev Genet 1995;29:729-754.
4. Coux O, Tanaka K, Goldberg AL. Structure and functions of the 20S and 26S proteasomes. Annu Rev Biochem 1996;65:801-847.
5. Hershko A, Ciechanover A. The ubiquitin system. Annu Rev Biochem 1998;67 (In press).
6. Goldberg AL, Rock KL. Proteolysis, proteasomes and antigen presentation. Nature 1992;357:375-379.
7. York IA, Rock KL. Antigen processing and presentation by the class I major histocompatibility complex. Annu Rev Immunol 1996;14:369-396.
8. Groettrup M, Soza A, Kuckelkorn U, Kloetzel P-M. Peptide antigen production by the proteasome: complexity provides efficiency. Immunol Today 1996;17:429-435.
9. Tanaka K, Tanahashi N, Tsurumi C, Yokota K, Shimbara N. Proteasomes and antigen processing. Adv Immunol 1997;64:1-38.
10. Kasahara M, et al. Chromosomal localization of the proteasome Z subunit gene reveals an ancient chromosomal duplication involving the major histocompatibility complex. Proc Natl Acad Sci USA 1996;93:9096-9101.
11. Androlewicz MJ, Cresswell P. How selective is the transporter associated with antigen processing? Immunity 1996;5:1-5.
12. Koopmann J-O, Hämmerling GJ, Momburg F. Generation, intracellular transport and loading of peptides associated with MHC class I molecules. Curr Opin Immunol 1997;9:80-88.
13. Williams DB, Watts TH. Molecular chaperones in antigen presentation. Curr Opin Immunol 1995;7:77-84.
14. Srivastava PK, Udono H, Blachere NE, Li Z. Heat shock proteins transfer peptides during antigen processing and CTL priming. Immunogenetics 1994;39:93-98.
15. Suto R, Srivastava PK. A mechanism for the specific immunogenicity of heat shock protein-chaperoned peptide. Science 1995;269:1585-1588.
16. Arnold D, Wahl C, Faath S, Rammensee HG, Schild H. Influences of transporter associated with antigen processing (TAP) on the repertoire of peptides associated with the endoplasmic reticulum-resident stress protein gp96. J Exp Med 1997;186:461-466.
17. Hochstrasser M. Ubiquitin-dependent protein degradation. Annu Rev Genet 1996;30:405-439.
18. Townsend A, et al. Defective presentation to class I-restricted cytotoxic T-lymphocytes in vaccinia-infected cells is overcome by enhanced degradation of antigen. J Exp Med 1988;168:1211-1224.
19. Michalek MT, Grant EP, Gramm C, Goldberg AL, Rock KL. A role for the ubiquitin-dependent proteolytic pathway in MHC class I-restricted antigen presentation. Nature 1993;363:552-554.
20. Grant EP, Michalek MT, Goldberg AL, Rock KL. Rate of antigen degradation by the ubiquitin-proteasome pathway influences MHC class I presentation. J Immunol 1995;155:3750-3758.
21. Tobery TW, Siliciano RF. Targeting of HIV-1 antigens for rapid intracellular degradation enhances cytotoxic T lymphocyte (CTL) recognition and the induction of de novo CTL responses in vivo after immunization. J Exp Med 1997;185:909-920.
22. Varshavsky A. The N-end rule. Cell 1992;69:725-735.
23. Ben-Shahar S, Cassouto B, Novak L, Porgador A, Reiss Y. Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate. J Biol Chem 1997;272:21060-21066.
24. Rock KL, et al. Inhibitors of the proteasome block the degradation of most proteins and the generation of peptides presented on MHC class I molecules. Cell 1994;78:761-771.
25. Harding CV, et al. Novel dipeptide aldehydes are proteasome inhibitors and block the MHC-I antigen-processing pathway. J Immunol 1995;155:1767-1775.
26. Craiu A, et al. Lactacystin and clasto-lactacystin β-lactone modify multiple proteasome β-subunits and inhibit protein degradation and major histocompatibility complex class I antigen presentation. J Biol Chem 1997;272:13437-13445.
27. Cerundolo V, et al. The proteasome-specific inhibitor lactacystin blocks presentation of cytotoxic T lymphocyte epitopes in human and murine cells. Eur J Immunol 1997;27:336-341.
28. Fehling HJ, et al. MHC class I expression in mice lacking the proteasome subunit LMP. Science 1994;265:1234-1237.
29. Van Kaer L, et al. Altered peptidase and viral specific T cell response in LMP2 mutant mice. Immunity 1994;1:533-541.
30. Boes B, Hengel H, Ruppert T, Multhaup G, Koszinowski UH, Kloetzel P-M. Interferon γ stimulation modulates the proteolytic activity and cleavage site preference of 20S mouse proteasome. J Exp Med 1994;179:901-909.
31. Niedermann G, et al. Contribution of proteasome-mediated proteolysis to the hierarchy of epitopes presented by major histocompatibility complex class I molecules. Immunity 1995;2:289-299.
32. Niedermann G, et al. The proteolytic fragments generated by vertebrate proteasomes: structural relationships to major histocompatibility complex class I binding peptides. Proc Natl Acad Sci USA 1996;93:8572-8577.
33. Ossendorp F, et al. A single residue exchange within a viral CTL epitope alters proteasome-mediated degradation resulting in lack of antigen presentation. Immunity 1996;5:115-124.
34. Dick TP, et al. Coordinated dual cleavages induced by the proteasome regulator PA28 lead to dominant MHC ligands. Cell 1996;86:253-262.
35. Shimbara N, et al. Double-cleavage production of the CTL epitope by proteasomes and PA28: Role of the flanking region. Genes to Cells 1998;3 (In press).
36. Baumeister W, Walz J, Zühl F, Seemüller E. The proteasome: Paradigm of a self-compartmentalizing protease. Cell 1998;92:367-380.
37. Groll M, et al. Structure of 20S proteasome from yeast at 2.4 Å resolution. Nature 1997;386:463-471.
38. Larsen CN, Finley D. Protein translocation channels in the proteasome and other protease. Cell 1997;91:431-434.
39. Tanaka K. Proteasomes: structure and biology. J Biochem 1998;123 (In press).
40. Patel S, Latterich M. The AAA team: related ATPases with diverse functions. Trends Cell Biol 1998;8:65-71.
41. Larsen F, Solheim J, Kristensen T, Kolsto A-B, Prydz H. A tight cluster of five unrelated human genes on chromosome 16q22.1. Hum Mol Genet 1993;2:1589-1595.
42. Akiyama K, et al. cDNA cloning and interferon γ down-regulation of proteasomal subunits X and Y. Science 1994;265:1231-1234.
43. Hisamatsu H, et al. Newly identified pair of proteasomal subunits regulated reciprocally by interferon-γ. J Exp Med 1996;183:1807-1816.
44. Belich M, Glynne RJ, Senger G, Sheer D, Trowsdale J. Proteasome components with reciprocal expression to that of the MHC-encoded LMP protein. Curr Biol 1994;4:769-776.
45. Früh K, Gossen M, Wang K, Bujard H, Peterson PA, Yang Y. Displacement of housekeeping proteasome subunits by MHC-encoded LMPs: a newly discovered mechanism for modulating the multicatalytic proteinase complex. EMBO J 1994;13:3236-3244.
46. Nandi D, Jiang H, Monaco JJ. Identification of MECL-1 (LMP-10) as the third IFN-γ-inducible proteasome subunit. J Immunol 1996;156:2361-2364.
47. Groettrup M, Kraft R, Kostka S, Standera S, Stohwasser R, Kloetzel P-M. A third interferon-γ-induced subunit exchange in the 20S proteasome. Eur J Immunol 1996;26:863-869.
48. Hayashi M, Ishibashi T, Tanaka K, Kasahara M. The mouse genes encoding the third pair of β-type proteasome subunits regulated reciprocally by IFN-γ: structural comparison, chromosomal localization, and analysis of the promoter. J Immunol 1997;159:2760-2770.
49. Aki M, et al. Interferon-γ induces different subunit organizations and functional diversity of proteasomes. J Biochem 1993;115:257-269.
50. Schmidt M, Kloetzel P-M. Biogenesis of eukaryotic 20S proteasomes: the complex maturation pathway of a complex enzyme. FASEB J 1997;11:1235-1243.
51. Seemüller E, Lupas A, Baumeister W. Autocatalytic processing of the 20S proteasome. Nature 1996;382:468-470.
52. Chen P, Hochstrasser M. Autocatalytic subunit processing couples active site formation in the 20S proteasome to completion of assembly. Cell 1996;86:961-972.
53. Schmidtke G, et al. Analysis of mammalian 20S proteasome biogenesis: the maturation of β-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J 1996;15:6887-6898.
54. Heinemeyer W, Fischer M, Krimmer T, Stachon U, Wolf DH. The active sites of the eukaryotic 20S proteasome and their involvement in subunit precursor processing. J Biol Chem 1997;272:25200-25209.
55. Groettrup M, Standera S, Stohwasser R, Kloetzel P-M. The subunits MECL-1 and LMP2 are mutually required for incorporation into the 20S proteasome. Proc Natl Acad Sci USA 1997;94:8970-8975.
56. Nandi D, Woodward E, Ginsburg DB, Monaco JJ. Intermediates in the formation of mouse 20S proteasomes: implications for the assembly of precursor β subunits. EMBO J 1997;16:5363-5375.
57. Griffin TA, et al. Immunoproteasome assembly: cooperative incorporation of interferon γ (IFN-γ)-inducible subunits. J Exp Med 1998;187:97-104.
58. Gaczynska M, Rock KL, Goldberg AL. γ-interferon and expression of MHC genes regulate peptide hydrolysis by proteasomes. Nature 1993;365:264-267.
59. Driscoll J, Brown MG, Finley D, Monaco JJ. MHC-linked LMP gene products specifically alter peptidase activities of the proteasome. Nature 1993;365:262-264.
60. Rammensee H-G, Friede T, Stevanovic S. MHC ligands and peptide motifs: first listing. Immunogenetics 1995;41:178-228.
61. Gaczynska M, Rock KL, Spies T, Goldberg AL. Peptidase activities of proteasomes are differentially regulated by the major histocompatibility complex-encoded genes for LMP2 and LMP7. Proc Natl Acad Sci USA 1994;91:9213-9217.
62. Gaczynska M, Goldberg AL, Tanaka K, Hendil KB, Rock KL. Proteasome subunits X and Y alter peptidase activities in opposite ways to the interferon-γ-induced subunits LMP2 and LMP7. J Biol Chem 1996,271:17275-17280.
63. Ustrell V, Pratt G, Rechsteiner M. Effects of interferon γ and major histocompatibility complex-encoded subunits on peptidase activities of human multicatalytic protease. Proc Natl Acad Sci USA 1995,92:584-588.
64. Kuckelkorn U, Frentzel S, Kraft R, Kostka S, Groettrup M, Kloetzel P-M. Incorporation of major histocompatibility complex-encoded subunits LMP2 and LMP7 changes the quality of the 20S proteasome polypeptide processing products independent of interferon-γ. Eur J Immunol 1995;25:2605-2611.
65. Zwickl P, Grziwa A, Pühler G, Dihlmann B, Lottspeich F, Baumeister W. Primary structure of the Thermoplasma proteasome and its implications for the structure, function, and evolution of the multicatalytic proteinase. Biochemistry 1992;31:964-972.
66. Hilt W, Wolf DH. Proteasomes: destruction as a programme. Trends Biochem Sci 1996;21:96-102.
67. Früh K, et al. Alternative exon usage and processing of the major histocompatibility complex-encoded proteasome subunits. J Biol Chem 1992;267:22131-22140.
68. Kishi F, Suminami Y, Monaco JJ. Genomic organization of the mouse Lmp-2 gene and characteristic structure of its promoter. Gene 1993;133:243-248.
69. Zhou P, Zanelli E, Smart M, David C. Genomic organization and tissue expression of mouse proteasome gene Lmp-2. Genomics 1993;16:664-668.
70. Woodward EC, Monaco JJ. Characterization and mapping of the gene encoding mouse proteasome subunit DELTA (Lmp19). Immunogenetics 1995;42:28-34.
71. Péléraux A, Karlsson L, Chambers J, Peterson PA. Genomic organization of a mouse MHC class II region including the H2-M and Lmp2 loci. Immunogenetics 1996;43:204-214.
72. Cruz M, Elenich LA, Smolarek TA, Menon AG, Monaco JJ. DNA sequence chromosomal localization, and tissue expression of the mouse proteasome subunit Lmp10 (Psmb10) gene. Genomics 1997;45:618-622.
73. Abdulla S, Beck S, Belich M, Jackson A, Nakamura T, Trowsdale J. Divergent intron arrangement in the MB1/LMP7 proteasome gene. Immunogenetics 1996;44:254-258.
74. Kohda K, Matsuda Y, Ishibashi T, Tanaka K, Kasahara M. Structural analysis and chromosomal localization of the Psmb5 gene coding for the constitutively expressed β-type proteasome subunit. Immunogenetics 1997;47:77-87.
75. Trowsdale J. Genomic structure and function in the MHC. Trends Genet 1993;9:117-122.
76. Katsanis N, Fitzgibbon J, Fischer EMC. Paralogy mapping: identification of a region in the human MHC triplicated onto human chromosomes 1 and 9 allows the prediction and isolation of novel PBX and NOTCH loci. Genomics 1996;35:101-108.
77. Kasahara M, Flajnik MF, Ishibashi T, Natori T. Evolution of the major histocompatibility complex: a current overview. Transplant Immunol 1995;3:1-20.
78. Litman GW, et al. Phylogenetic diversification of immunoglobulin genes and the antibody repertoire. Mol Biol Evol 1993;10:60-72.
79. Rast JP, Anderson MK, Strong SJ, Luer C, Litman RT, Litman GW. α, β, γ, and δ T cell antigen receptor genes arose early in vertebrate phylogeny. Immunity 1997;6:1-11.
80. Thompson CB. New insights into V(D)J recombination and its role in the evolution of the immune system. Immunity 1995;3:531-539.
81. Kasahara M. New insights into the genomic organization and origin of the major histocompatibility complex: role of chromosomal (genome) duplication in the emergence of the adaptive immune system. Hereditas 1997;127:59-65.
82. Kasahara M, Vazquez M, Sato K, McKinney EC, Flajnik MF. Evolution of the major histocompatibility complex: Isolation of class II A cDNA clones from the cartilaginous fish. Proc Natl Acad Sci USA 1992;89:6688-6692.
83. Hashimoto K, Nakanishi T, Kurosawa Y. Identification of a shark sequence resembling the major histocompatibility complex class I α3 domain. Proc Natl Acad Sci USA 1992;89:2209-2212.
84. Kandil E, et al. Isolation of low molecular mass polypeptide complementary DNA clones from primitive vertebrates: implications for the origin of MHC class I-restricted antigen presentation. J Immunol 1996;156:4245-4253.
85. Nonaka M, Namikawa-Yamada C, Sasaki M, Salter-Cid L, Flajnik MF. Evolution of proteasome subunits δ and LMP2: complementary DNA cloning and linkage analysis with MHC in lower vertebrates. J Immunol 1997;159:734-740.
86. Parmentier Y, Bouchez D, Fleck J, Genschik P. The 20S proteasome gene family in Arabidopsis thalian. FEBS Lett 1997;416:281-285.
87. Higgins CF. ABC transporters: From microorganisms to man. Annu Rev Cell Biol 1992;8:67-113.
88. Robey E. Notch in vertebrates. Curr Opin Genet Dev 1997;7:551-557.
89. Farries TC, Atkinson JP. Evolution of the complement system. Immunol Today 1991;12:295-300.
90. Kasahara M, Nakaya J, Satta Y, Takahata N. Chromosomal duplication and the emergence of the adaptive immune system. Trends Genet 1997;13:90-92.
91. Ohno S. Evolution by gene duplication. New York: Springer-Verlag; 1970.
92. Sharman AC, Holland PWH. Conservation, duplication, and divergence of developmental genes during chordate evolution. Neth J Zool 1996;46:47-67.
93. Sidow A. Gen(om)e duplications in the evolution of early vertebrates. Curr Opin Genet Dev 1996;6:715-722.
94. Ma C-P, Slaughter CA, DeMartino GN. Identification, purification, and characterization of a protein activator (PA28) of the 20S proteasome (macropain). J Biol Chem 1992;267:10515-10523.
95. Dubiel W, Pratt G, Ferrell K, Rechsteiner M. Purification of an 11S regulator of the multicatalytic protease. J Biol Chem 1992;267:22369-22377.
96. Gray CW, Slaughter CA, DeMartino GN. PA28 activator protein forms regulatory caps on proteasome stacked rings. J Mol Biol 1994;236:7-15.
97. Ahn JY, et al. Primary structures of two homologous subunits of PA28, a γ-interferon-inducible protein activator of the 20S proteasome. FEBS Lett 1995;366:37-42.
98. Nikaido T, et al. Cloning and nucleotide sequence of cDNA for Ki antigen, a highly conserved nuclear protein detected with sera from patients with systemic lupus erythematosus. Clin Exp Immunol 1990;79:209-214.
99. Tanahashi N, et al. Molecular properties of the proteasome activator PA28 family proteins and γ-interferon regulation. Genes to Cells 1997;2:195-211.
100. Song X, et al. A model for the quaternary structure of the proteasome activator PA28. J Biol Chem 1996;271:26410-26417.
101. Soza A, Knuehl C, Groettrup M, Henklein P, Tanaka K, Kloetzel P-M. Expression and subcellular localization of mouse 20S proteasome activator complex PA28. FEBS Lett 1997;413:27-34.
102. Realini C, Dubiel W, Pratt G, Ferrell K, Rechsteiner M. Molecular cloning and expression of a γ-interferon-inducible activator of the multicatalytic protease. J Biol Chem 1994;269:20727-20732.
103. Knowlton JR, et al. Structure of the proteasome activator REGα (PA28α). Nature 1997;390:639-643.
104. Kuehn L, Dahimann B. Reconstruction of proteasome activator PA28 from isolated subunits: optimal activity is associated with an α,β-heterodimer. FEBS Lett 1996;394:183-186.
105. Song X, von Kampen J, Slaughter CA, DeMartino GN. Relative functions of the α and β subunits of the proteasome activator, PA28. J Biol Chem 1997;272:27994-28000.
106. Realini C, et al. Characterization of recombinant REGα, REGβ, and REGγ proteasome activators. J Biol Chem 1997;272:25483-25492.
107. Honoré B, Leffers H, Madsen P, Celis JE. Interferon-γ up-regulates a unique set of proteins in human keratinocytes. Molecular cloning and expression of the cDNA encoding the RGD-sequence-containing protein IGUP I-5111. Eur J Biochem 1993;218:421-430.
108. Jiang H, Monaco JJ. Sequence and expression of mouse proteasome activator PA28 and the related autoantigen. Immunogenetics 1997;46:93-98.
109. Groettrup M, et al. The interferon-γ-inducible 11 S regulator (PA28) and the LMP2/LMP7 subunits govern the peptide production by the 20 S proteasome in vitro. J Biol Chem 1995;270:23808-23815.
110. Groettrup M, et al. A role for the proteasome regulator PA28α in antigen presentation. Nature 1996;381:166-168.
111. Paesen GC, Nuttall PA. A tick homologue of the human Ki nuclear autoantigen. Biochim Biophys Acta 1996;1309:9-13.
112. Kandil E, Kohda K, Ishibashi T, Tanaka K, Kasahara M. PA28 subunits of the mouse proteasome: primary structures and chromosomal localization of the genes. Immunogenetics 1997;46:337-344.
113. Kohda K, Ishibashi T, Shimbara N, Tanaka K, Matsuda Y, Kasahara M. Characterization of the mouse PA28 activator complex gene family: complete organizations of the three member genes and a physical map of the ∼150-kb region containing the α- and β-subunit genes. J Immunol 1998;160:4923-4935.
114. Albertsen HM, et al. A physical map and candidate genes in the BRCA1 region on chromosome 17q12-21. Nat Genet 1994;7:472-479.
115. McCusker D, Jones T, Sheer D, Trowsdale J. Genetic relationships of the genes encoding the human proteasome β subunits and the proteasome PA28 complex. Genomics 1997;45:362-367.
116. Darnell JE Jr, Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994;264:1415-1421.
117. Boehm U, Klamp T, Groot M, Howard JC. Cellular responses to interferon-γ. Annu Rev Immunol 1997;15:749-795.
118. Epperson DE, Arnold D, Spies T, Cresswell P, Pober JS, Johnson DR. Cytokines increase transporter in antigen processing-1 expression more rapidly than HLA class I expression in endothelial cells. J Immunol 1992;149:3297-3301.
119. Min W, Pober JS, Johnson DR. Kinetically coordinated induction of TAP1 and HLA class I by IFN-γ: the rapid induction of TAP1 by IFN-γ is mediated by Stat1α. J Immunol 1996;156:3174-3183.
120. Wright KL, White LC, Kelly A, Beck S, Trowsdale J, Ting JP-Y. Coordinate regulation of the human TAP1 and LMP2 genes from a shared bidirectional promoter. J Exp Med 1995;181:1459-1471.
121. Wang X, et al. Rapamycin inhibits proteasome activator expression and proteasome activity. Eur J Immunol 1997;27:2781-2786.
122. Yoshimura T, et al. Molecular characterization of the "26S" proteasome complex from rat liver. J Struct Biol 1993;111:200-211.
123. Peters J-M, Cejka Z, Harris JR, Kleinschmidt JA, Baumeister W. Structural features of the 26S proteasome complex. J Mol Biol 1993;234:932-937.
124. Kopp F, Hendil KB, Dahimann B, Kristensen P, Sobek A, Uerkvitz W. Subunit arrangement in the human 20S proteasome. Proc Natl Acad Sci USA 1997;94:2939-2944.
125. Glynne R, Kerr L-A, Mockridge I, Beck S, Kelly A, Trowsdale J. The major histocompatibility complex-encoded proteasome component LMP7: alternative first exons and post-translational processing. Eur J Immunol 1993;23:860-866.
126. Meinhardt T, Gräf U, Hämmerling G. Different genomic structure of mouse and human Lmp7 genes: characterization of MHC-encoded proteasome genes. Immunogenetics 1993;38:373-379.
127. Realini C, Rogers SW, Rechsteiner M. KEKE motifs: Proposed roles in protein-protein association and presentation of peptides by MHC class I receptors. FEBS Lett 1994;348:109-113.